— Know what they know.
Not Investment Advice

EVIO OTC

EVIO, Inc.
1W: +0.0% 1M: -98.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -99.0% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
Weekly Expected Move ±5196.4%
$-0 $-0 $0 $0 $0
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 47 · $959685 mcap · 10.12B float · 0.030% daily turnover · Short 23% of daily vol

Income Trends

Revenue
$2M -32.7% ▼
5Y CAGR: -12.0%
Gross Profit
$525K +58.1% ▲
5Y CAGR: -1.4%
Operating Income
-$1M +63.4% ▲
Net Income
$48K +105.0% ▲
EPS (Diluted)
$0.00 +100.0% ▲
EBITDA
$713K -50.3% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2018FY2019FY2020FY2021FY2022
Revenue$3M$4M$4M$2M$2M
YoY Growth+11.4%+12.6%-5.1%-34.3%-32.7%
Cost of Revenue$4M$5M$4M$2M$1M
Gross Profit-$472K-$936K$58K$332K$525K
Gross Margin-14.0%-24.7%1.6%14.0%33.0%
R&D Expenses$0$0$0$0$0
SG&A Expenses$8M$6M$4M$4M$2M
Operating Expenses$8M$6M$4M$4M$2M
Operating Income-$8M$297K-$4M-$4M-$1M
Operating Margin-242.9%7.8%-117.2%-159.9%-87.0%
Interest Expense$5M$6M$5M$3M$757K
Income Before Tax-$12M-$21M-$8M-$2M-$505K
Tax Expense$0$8K$124$0$0
Net Income-$12M-$21M-$8M-$965K$48K
Net Margin-345.7%-545.4%-234.0%-40.8%3.0%
EPS (Diluted)$-0.70$-0.77$-0.12$-0.00$0.00
EBITDA-$7M-$6M-$3M$1M$713K
Shares Outstanding17M27M72M1.61B1.61B

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms